Regulation of ROS generation, NADPH oxidase activity, Caspase 3 activity, Caspase 9 activity, and GSH levels in human ESCC cell lines treated with thapsigargin and the TRAIL. This evidence concerns the gene FMO5 and esophageal squamous cell carcinoma.